Current Regulatory Requirements for Biosimilars in Six Member Countries of BRICS-TM: Challenges and Opportunities

Background: The aim of the study was to identify, interpret, and compare the current perspectives of regulatory agencies in six member countries of BRICS-TM (Brazil, Russia, India, China, South Africa, Turkey, and Mexico) on the different criteria used for biosimilar development and marketing author...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahalkar, Hasumati, Sheppard, Alan, Santos, Gustavo Mendes Lima, Dasgupta, Chitralekha, Perez-Tapia, Sonia Mayra, Lopez-Morales, Carlos A., Salek, Sam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458962/
https://www.ncbi.nlm.nih.gov/pubmed/34568384
http://dx.doi.org/10.3389/fmed.2021.726660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458962/
https://www.ncbi.nlm.nih.gov/pubmed/34568384
http://dx.doi.org/10.3389/fmed.2021.726660

Ejemplares similares